Home  >  Products  >  KLRC2 (killer cell lectin-like receptor subfamily C, member 2 ) Blocking Peptide (the C terminal of KLRC2)(100ug)
KLRC2 (killer cell lectin-like receptor subfamily C, member 2 ) Blocking Peptide (the C terminal of KLRC2)(100ug)

KLRC2 (killer cell lectin-like receptor subfamily C, member 2 ) Blocking Peptide (the C terminal of KLRC2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-KLRC2 Antibody (ARP63956_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63956
Size: 100ug
Weight: 26kDa
Gene: 3822
Format: Lyophilized powder
Target: Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. The group, designated KLRC (NKG2) are expressed primarily in natural killer (NK) cells and encodes a family of transmembrane proteins characterized by a type II membrane orientation (extracellular C terminus) and the presence of a C-type lectin domain. The KLRC (NKG2) gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed on NK cells. KLRC2 alternative splice variants have been described but their full-length nature has not been determined.
Alternative names: CD159c; MGC138244; NKG2-C; NKG2C
See Full Product Listings >